Health Condition 1: null- Primary hypertension
Conditions
Interventions
Intervention1: Sharbat aftimoon: 25 ml bd for 2 months orally
Control Intervention1: losartan: 50 mg od for 2 months orally
Sponsors
National Institute of Unani Medicine
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients with stage- 1 primary hypertension ranging systolic pressure140 to 159 mmHg and diastolic pressure 90 to 99 mmHg. 2.Patients who will agree to sign the informed consent form and follow up the protocol. 3.Age group: 30 to 65 years. 4.Gender:Either
Exclusion criteria
Exclusion criteria: 1.Patients with cardiac arrhythmias (chronic atrial fibrillation, frequent premature ventricular and atrial contractions, ventricular or supraven¬tricular tachycardia, tachycardia [heart rate > 100 beats per minute]), atrioventricular block. 2.Patients with malignant hypertension. 3.Patients with the episodes of marked arterial hypotension (systolic BP 4.Patients with the history of myocardial infarction or acute cerebrovascular events, stable angina or vasospastic angina, valvular diseases. 5.Patients with the positive history of angioedema. 6.Patients with the history of chronic liver disease, acute or chronic renal failure, Bronchial asthma and Diabetes mellitus. 7.Lactating mothers and pregnant women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Decrease in systolic blood pressureTimepoint: 2 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Reversal of arterial stiffnessTimepoint: 2 months | — |
Countries
India
Contacts
Public ContactDr Mohd Aleemuddin Quamri
National Institute of Unani Medicne
Outcome results
None listed